UG Healthcare Corporation FY2025 Results: Revenue Grows, Net Loss Narrows
Link: https://links.sgx.com/1.0.0/corporate-announcements/5FSNT6E6UWWM0D0X/1da0682305137edb87ba202615f150694fa43ea0c362bc6c764d4c54eadfc250
Summary:
-
Revenue: Up 25.1% to S$144.1 million (FY24: S$115.2 million), driven by higher sales volumes across latex, nitrile, and ancillary products. Nitrile glove and non-glove hygiene products posted the strongest gains.
-
Gross Profit: Rose 34.3% to S$34.7 million; gross margin improved to 24.1% (from 22.5%).
-
Net Loss (attributable to owners): Narrowed by 37.4% year-on-year to S$3.8 million (FY24: S$6.1 million loss).
-
Loss per share: 0.61 cents (vs. 0.97 cents FY24).
-
Key markets: Revenue rose sharply in Europe (up 38.8%) and North America (more than doubled), offsetting a decline in South America. Asia, Africa, and Other markets also grew.
-
Expenses & Profitability: Operating expenses up 9.4% (mainly marketing, distribution, staff cost). Operating loss narrowed; finance costs up (loan for Unigloves Germany stake, increased trade facilities). Net asset value per share at S$0.2545 (down slightly from S$0.2619).
-
Cash & Bank: S$23.3 million at year-end (down from S$28.0 million); total borrowings (short- and long-term) up slightly due to expansion.
-
Strategic Focus: The group is expanding its downstream distribution in Europe, North America, and Africa to respond rapidly to market trends and demand. Margin improvement reflects better product mix and operational scale.
-
Outlook: Market remains highly competitive due to global trade/tariff uncertainty and volatile currency. Management expects growth through its integrated brand and manufacturing model.